Lenvima and Basaglar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lenvima (lenvatinib mesylate) and Basaglar (insulin glargine). Common drug interactions include asthenia among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Lenvima and Basaglar. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Lenvima?

Lenvima has active ingredients of lenvatinib mesylate. eHealthMe is studying from 21,113 Lenvima users. Check the latest studies of Lenvima.

What is Basaglar?

Basaglar has active ingredients of insulin glargine. eHealthMe is studying from 19,807 Basaglar users. Check the latest studies of Basaglar.

On Jul, 12, 2026

16 people who take Lenvima and Basaglar together, and have interactions are studied.

What are the common drug interactions of Lenvima and Basaglar, by gender? *:

female:

Asthenia (weakness)
Dyspnoea (difficult or laboured respiration)
Nausea (feeling of having an urge to vomit)
Blood pressure increased
Diarrhoea
Dizziness
Headache (pain in head)
Vomiting
Epistaxis (bleed from the nose)
Abdominal pain

male:

Pneumonia
Ammonia increased
Intestinal perforation (complete penetration of the wall of the intestine)
Malignant neoplasm progression (cancer tumour came back)
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
Blood pressure increased
Constipation
Furuncle (infection of the hair follicle)
Intestinal obstruction
Nausea (feeling of having an urge to vomit)

What are the common drug interactions of Lenvima and Basaglar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Intestinal perforation (complete penetration of the wall of the intestine)
Pneumonia

50-59:

Blood pressure increased
Nausea (feeling of having an urge to vomit)
Asthenia (weakness)
Diarrhoea
Dizziness
Dyspnoea (difficult or laboured respiration)
Headache (pain in head)
Vomiting
Pulmonary embolism (blockage of the main artery of the lung)
Ammonia increased

60+:

Dyspnoea (difficult or laboured respiration)
Alopecia (absence of hair from areas of the body)
Myalgia (muscle pain)
Nausea (feeling of having an urge to vomit)
Stomatitis (inflammation of mucous membrane of mouth)
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
Vomiting
Weight decreased
Arthralgia (joint pain)
Constipation

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 7 people, 43.75%
Thyroid Cancer: 4 people, 25.00%
Type 2 Diabetes: 2 people, 12.50%
Thyroid Diseases: 2 people, 12.50%
Endometrial Cancer: 2 people, 12.50%
Multiple Myeloma (cancer of the plasma cells): 1 person, 6.25%
Hepatocellular Carcinoma (liver cancer): 1 person, 6.25%
Endometrial Neoplasm (tumour of uterus wall): 1 person, 6.25%
Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Lenvima and Basaglar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously